Sientra (NASDAQ:SIEN – Get Free Report)‘s stock had its “hold” rating reissued by equities researchers at Craig Hallum in a research note issued on Tuesday, Benzinga reports.
Separately, StockNews.com assumed coverage on shares of Sientra in a research report on Thursday, October 5th. They issued a “hold” rating for the company.
Read Our Latest Stock Analysis on SIEN
Sientra Stock Performance
Sientra (NASDAQ:SIEN – Get Free Report) last announced its quarterly earnings data on Thursday, August 10th. The medical instruments supplier reported ($0.85) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.88) by $0.03. The company had revenue of $23.13 million for the quarter, compared to the consensus estimate of $25.00 million. As a group, equities analysts predict that Sientra will post -2.77 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the business. Mirabella Financial Services LLP bought a new position in Sientra during the first quarter worth $26,000. Advisor Group Holdings Inc. boosted its holdings in shares of Sientra by 230.9% during the 1st quarter. Advisor Group Holdings Inc. now owns 11,930 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 8,325 shares during the period. LPL Financial LLC bought a new stake in shares of Sientra during the 2nd quarter worth about $31,000. Virtu Financial LLC bought a new position in Sientra in the 2nd quarter valued at about $32,000. Finally, Wolverine Trading LLC acquired a new stake in Sientra during the second quarter worth approximately $32,000. 15.38% of the stock is owned by institutional investors and hedge funds.
About Sientra
Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.
Featured Articles
- Five stocks we like better than Sientra
- Pros And Cons Of Monthly Dividend Stocks
- First Solar, an affordable, high-quality green investment
- Which Wall Street Analysts are the Most Accurate?
- 5 Dow stocks to track during the market correction
- What Are Dividend Achievers? An Introduction
- Lean on these stocks during GDP expansion
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.
